Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems-Trading Strong Earnings Growth and Momentum -- Ignore unavailable to you. Want to Upgrade?

To: Jenna who wrote (3308)	1/29/2001 2:27:46 PM
From: Jenna	Respond to of 6445

BIOI DJ BioSource Intl Sees 2001 Sales $38.1M Vs $32.3M marketgems.com >BIOI PRE-MARKET NEWS POSTED IN BIotechnology. (MORE) DOW JONES NEWS 01-29-01 07:57 AM - - 07 57 AM EST 01-29-01 -------------------- TAL News Server History: ADD : 01/01/29 07:57 PARTIAL REPLACE : 01/01/29 08:01 -------------------------------------------------- +DJ BioSource Intl Sees 18% Sales Growth In 2001 >BIOI (MORE) DOW JONES NEWS 01-29-01 07:56 AM - - 07 56 AM EST 01-29-01 -------------------- TAL News Server History: ADD : 01/01/29 07:56 PARTIAL REPLACE : 01/01/29 07:57 -------------------------------------------------- DJ BioSource Intl Sees 2001 Oper Profit $5.5M Vs $4.2M>BIOI (MORE) DOW JONES NEWS 01-29-01 07:57 AM - - 07 57 AM EST 01-29-01 -------------------- TAL News Server History: ADD : 01/01/29 07:57 PARTIAL REPLACE : 01/01/29 07:57 -------------------------------------------------- DJ BioSource Intl Estimate -2: Sees 4Q Chg Of $1.6M-$1.8M CAMARILLO, Calif. (Dow Jones)--BioSource International Inc. (BIOI) expects to take a fourth quarter charge of $1.6 million to $1.8 million in severance costs for European personnel and other merger and acquisition fees, as well as a $300,000 charge noncash stock compensation charge. In a press release Monday, the life sciences company said it expects year sales of $32.3 million, compared with $29.3 million in 1999. Operating profit for 2000 is expected to be $4.2 million, compared with $4.6 million a year ago. In 1999, BioSource earned $3.6 million, or 46 cents a diluted share. For 2001, BioSource said it expects sales of $38.1 million and operating profit of $5.5 million. The company expects 2001 sales growth of 18% excluding acquisitions, compared with 10.4% in 2000. BioSource will release 2000 results the week of Feb. 26. Company Web site: biosource.com -Stephen Lee; Dow Jones Newswires; 201-938-5400